Use of fibrin sealants for the localized, controlled release of cefazolin

Canadian Journal of Surgery

Volumn 49, Issue 5, 2006, Pages 347-352

  Tredwell, Stephen ^a   Jackson, John K ^b   Hamilton, Donald ^a   Lee, Vivian ^b   Burt, Helen M ^b  

^a BC CHILDREN S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; ERYTHROMYCIN; FIBRIN GLUE; PHOSPHATE BUFFERED SALINE;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STABILITY; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; PRECIPITATION; SPECTROSCOPY;

ANTI-BACTERIAL AGENTS; CEFAZOLIN; DELAYED-ACTION PREPARATIONS; FIBRIN TISSUE ADHESIVE; HUMANS; SPECTRUM ANALYSIS;

EID: 33845295089     PISSN: 0008428X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Spotnitz WD. Commercial fibrin sealants in surgical care. Am J Surg 2001;182:8S-14S.
2. Reece TB, Maxey TS, Kron IL. A prospectus on tissue adhesives. Am J Surg 2001;182:40S-44S.
3. Jackson MR. Fibrin sealants in surgical practice: an overview. Am J Surg 2001;182:1S-7S.
4. Mankad PS, Codispoti M. The role of fibrin sealants in hemostasis. Am J Surg 2001;182:21S-28S.
5. Jackson MR, MacPhee MJ, Drohan WN, et al. Fibrin sealant: current and potential clinical applications. Blood Coagul Fibrinolysis 1996;7:737-46.
6. Sierra DH. Fibrin sealant adhesive systems: a review of their chemistry, material properties, and clinical applications. J Biomater Appl 1993;7:309-52.
7. Thompson DF, Davis TW. The addition of antibiotics to fibrin glue. South Med J 1997;90:681-4.
8. Redl H, Schlag G, Stanek G, et al. In vitro properties of mixtures of fibrin seal and antibiotics. Biomaterials 1983;4:29-32.
9. Kitazawa H, Sato H, Adachi I, et al. Microdialysis assessment of fibrin glue containing sodium alginate for local delivery of doxorubicin in tumour-bearing rats. Biol Pharm Bull 1997;20:278-81.
10. Miura S, Mii Y, Miyauchi Y, et al. Efficacy of slow-releasing anticancer drug delivery systems on transplantable osteosarcomas in rats. Jpn J Clin Oncol 1995;25:61-71.
11. Zarge J, Husak IV, Huang P, et al. Fibrin glue containing fibroblast growth factor type 1 and heparin decreases platelet deposition. Am J Surg 1997;174:188-92.
12. Woolverton CJ, Fulton JA, Salstrom S, et al. Tetracycline delivery from fibrin controls peritoneal infection without measurable systemic antibiotic. J Antimicrob Chemother 2001;48:861-7.
13. Marone P, Monzillo V, Segu C, et al. Antibiotic-impregnated fibrin glue in ocular surgery: in vitro antibacterial activity. Ophthalmologica, 1999;213:12-5.
14. Kram HB, Bansal M, Timberlake O, et al. Antibacterial effects of fibrin glue-antibiotic mixtures. J Surg Res 1991;50:175-8.
15. Park MS, Kim YB. Sustained release of antibiotic form a fibrin-gelatin-antibiotic mixture. Laryngoscope 1997;107:1378-81.
16. Fujimoto K, Yamamura K, Osada T, et al. Subcutaneous tissue distribution of vancomycin from a fibrin glue/Dacron graft carrier. J Biomed Mater Res 1997;36:564-7.
17. Osada T, Yamamura K, Yano K, et al. Distribution and serum concentration of sisomicin released from fibrin glue-sealed Dacron graft in the rat and human. J Biomed Mater Res 2000;52:53-7.
18. Morikawa T. Tissue sealing. Am J Surg 2001;182:29S-35S.
19. Schenk WG, Burks SG, Gagne PH, et al. Fibrin sealant improves hemostasis in peripheral vascular surgery: a randomized prospective trial. Ann Surg 2003;237:871-6.
20. Jackson MR. New and potential uses of fibrin sealants as an adjunct to surgical hemostasis. Am J Surg 2001;182:36S-39S.
21. Soffer E, Ouhayoun JP, Anagnostou F. Fibrin sealants and platelet preparations in bone and periodontal healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:521-8.